Express Scripts has recently begun targeting deals with drug makers that would link the price of cancer medicines to their performance against different tumor types. Although similar price deals exist in other countries, the United States’ fragmented patient-record system would be a definite challenge. Read more here. (Source: Matthew Dennis, FirstWord Pharma, 5/27/15)
You are here: / / Will Pay-For-Performance Deals on Cancer Drugs Work in America?